Evidence map›Paper›PMID 34722723›Full record

ArticleVisceral medicine2021

A Novel Hybrid Stent with Endoscopic Vacuum Therapy for Treating Leaks of the Upper Gastrointestinal Tract.

Seung-Hun Chon, Ulrich Töx, Florian Lorenz, Isabel Rieck, Britta Janina Wagner, Robert Kleinert, Hans Friedrich Fuchs, Tobias Goeser, Alexander Quaas, Christiane J Bruns

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Visceral medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Treatment of esophageal leakages with the MicrotechTherapeutic advances in gastrointestinal endoscopy
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Seung-Hun ChonDepartment of General, Visceral, Cancer, and Transplant Surgery, University Hospital Cologne, Cologne, Germany.
Ulrich TöxDepartment of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, Germany.
Florian LorenzDepartment of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, Germany.
Isabel RieckDepartment of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, Germany.
Britta Janina WagnerDepartment of Pathology, University Hospital Cologne, Cologne, Germany.
Robert KleinertDepartment of General, Visceral, Cancer, and Transplant Surgery, University Hospital Cologne, Cologne, Germany.
Hans Friedrich FuchsDepartment of General, Visceral, Cancer, and Transplant Surgery, University Hospital Cologne, Cologne, Germany.
Tobias GoeserDepartment of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, Germany.
Alexander QuaasDepartment of Pathology, University Hospital Cologne, Cologne, Germany.
Christiane J BrunsDepartment of General, Visceral, Cancer, and Transplant Surgery, University Hospital Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSelf-expanding metal stents (SEMS) are an established option for treating leaks in the upper gastrointestinal tract, and endoscopic vacuum therapy (EVT) has become a promising alternative. A novel approach is the use of an esophageal hybrid SEMS (VACStent®), which can maintain esophageal passage during EVT. We present the first study demonstrating successful use of the VACStent® for treating leaks of the upper gastrointestinal tract.

methodWe performed a retrospective, single-center study of all patients who underwent endoscopic stenting with the VACStent® of leaks in the upper gastrointestinal tract.

resultsIndications for treatment with the VACStent® were: iatrogenic esophageal perforation (

conclusionThe initial experience has been that the technical application of the VACStent® is safe and technically feasible. However, due to the small number of patients this study could not show the clear advantages of this novel hybrid stent. More studies are necessary to show significant advantages.

Indexed as

Anastomotic leakEndoscopic vacuum therapyEsophageal perforationSelf-expanding metal stent

Identifiers

PMID34722723
PMCPMC8543322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.